Related references
Note: Only part of the references are listed.Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells
Tengfei Bian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A novel spiroindoline targets cell cycle and migration via modulation of microtubule cytoskeleton
Naveen Kumar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors
Manu Anantpadma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Design and synthesis of novel tamoxifen analogues that avoid CYP2D6 metabolism
Nermin S. Ahmed et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design and synthesis of novel flexible ester-containing analogs of tamoxifen and their evaluation as anticancer agents
Nehal H. Elghazawy et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Spiro[pyrrolidine-3, 3′-oxindole] as potent anti-breast cancer compounds:Their design, synthesis, biological evaluation and cellular target identification
Santanu Hati et al.
SCIENTIFIC REPORTS (2016)
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity
Papiya Majumdar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?
J. Bines et al.
ANNALS OF ONCOLOGY (2014)
Influence of the Length and Positioning of the Antiestrogenic Side Chain of Endoxifen and 4-Hydroxytamoxifen on Gene Activation and Growth of Estrogen Receptor Positive Cancer Cells
Philipp Y. Maximov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters
Hiltrud Brauch et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Synthesis of Mixed (E,Z)-, (E)-, and (Z)-Norendoxifen with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities
Wei Lv et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Tamoxifen Resistance in Breast Cancer
Minsun Chang
BIOMOLECULES & THERAPEUTICS (2012)
Tamoxifen non-estrogen receptor mediated molecular targets
Tatiana Bogush et al.
ONCOLOGY REVIEWS (2012)
The hydrolytic activity of esterases in the yeast Saccharomyces cerevisiae is strain dependent
Magdalena Kwolek-Mirek et al.
CELL BIOLOGY INTERNATIONAL (2011)
CYP2D6 Genotyping and Tamoxifen: An Unfinished Story in the Quest for Personalized Medicine
Jonas A. de Souza et al.
SEMINARS IN ONCOLOGY (2011)
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment
T. Ramon y Cajal et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Biochemical Target Isolation for Novices: Affinity-Based Strategies
Shin-ichi Sato et al.
CHEMISTRY & BIOLOGY (2010)
Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver
Isabelle Larosche et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen
YC Lim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Dissecting physiological roles of estrogen receptor α and β with potent selective ligands from structure-based design
A Hillisch et al.
MOLECULAR ENDOCRINOLOGY (2004)
Absorption rate limit considerations for oral phosphate prodrugs
T Heimbach et al.
PHARMACEUTICAL RESEARCH (2003)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes:: Formation of the 4-hydroxy, 4′-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen
HK Crewe et al.
DRUG METABOLISM AND DISPOSITION (2002)
SERMs: Evolutionary chemistry, revolutionary biology
CP Miller
CURRENT PHARMACEUTICAL DESIGN (2002)
Flexible estrogen receptor modulators: Design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells
MJ Meegan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Selective estrogen receptor modulators (SERMs): Effects on multiple organ systems
D Agnusdei et al.
CURRENT MEDICINAL CHEMISTRY (2000)
Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59)
J Shibata et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Share Paper
